Holding Company

Riemser Arzneimittel AG

RIEMSER Arzneimittel AG is a company with tradition and a future. Following its demerger from the Friedrich-Loeffler-Institute Riems Island (FLI), RIEMSER Arzneimittel AG has, within a period of just a few years, evolved to become one of East Germany’s largest producers and developers of pharmaceutical products.

RIEMSER Arzneimittel AG has affiliated branches in such German Federal States such as Saarland, Baden-Wuerttemberg, and Saxony as well as abroad.

RIEMSER AG carries a well-diversified portfolio, which encompasses the areas human, veterinary, and dental. Its core competencies focus on oncology and dermatology as well as on dental products and anti-infective, in veterinary, the emphasis is on animal vaccines.

 

Production sites and affiliates:

Münster Business unit Oncology Sales Office		Greifswald Insel Riems RIEMSER Arzneimittel AG Human / Headquarter
		Hohen Neuendorf primoJEX GmbH
Schiffweiler FATOL Arzneimittel GmbH Production site of Riemser Arzneimittel AG		Berlin Riesmer Arzneimittel AG Production site RÖSCH Medizintechnik
		Leipzig Leipziger Arzneimittelwerk Production site of Riemser Arzneimittel AG
	Laupheim RIEMSER Specialty Production GmbH Contract manufacturing	Kleinostheim RIEMSER Arzneimittel AG Business unit Dental Sales Office